| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.05 |
| mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.05 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
| mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.05 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.05 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.05 |
| mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.05 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.06 |